LALPATHLAB Q2 Results: revenue rise 8.94% to 660.00 and net profit rise 15.27% to 131.00 YoY
NSE: LALPATHLAB :Rs.3,250.00 (-1.81%) Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and…